{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:30:10Z","timestamp":1792524610780,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier","isbn-type":[{"value":"9780128126035","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.irn.2017.05.019","type":"book-chapter","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T23:31:41Z","timestamp":1498606301000},"page":"859-876","source":"Crossref","is-referenced-by-count":47,"title":["Sexual Dysfunctions in Parkinson's Disease: An Underrated Problem in a Much Discussed Disorder"],"prefix":"10.1016","author":[{"given":"Kalyan B.","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rosa-Grilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/bs.irn.2017.05.019_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01254926","article-title":"Effects of pergolide and bromocriptine on male rat sexual behavior","volume":"54","author":"Ahlenius","year":"1982","journal-title":"Journal of Neural Transmission"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.019_bb0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":"Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation","volume":"21","author":"Ardouin","year":"2006","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.019_bb0015","first-page":"28","article-title":"Determinants of sexual dysfunction in male and female patients with Parkinson's disease","volume":"26","author":"Atag\u00fcn","year":"2013","journal-title":"The Journal of Psychiatry and Neurological Sciences"},{"issue":"2\u20133","key":"10.1016\/bs.irn.2017.05.019_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00224490902747222","article-title":"The dual control model: Current status and future directions","volume":"46","author":"Bancroft","year":"2009","journal-title":"Journal of Sex Research"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1353-8020(96)00020-X","article-title":"Sexuality and Parkinson's disease","volume":"2","author":"Basson","year":"1996","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2017.05.019_bb0030","first-page":"295","article-title":"Sex and idiopathic Parkinson's disease","volume":"86","author":"Basson","year":"2001","journal-title":"Advances in Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.019_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2004.06.005","article-title":"Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: A pilot study","volume":"76","author":"Bearn","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"5304","key":"10.1016\/bs.irn.2017.05.019_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1126\/science.275.5304.1293","article-title":"Deciding advantageously before knowing the advantageous strategy","volume":"275","author":"Bechara","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000020247","article-title":"Anatomy and physiology of female sexual function and dysfunction: Classification, evaluation and treatment options","volume":"38","author":"Berman","year":"2000","journal-title":"European Urology"},{"key":"10.1016\/bs.irn.2017.05.019_bb0050","unstructured":"Bhattacharyya, K., Das, D., Bose, P., Datta, A., Mandal, B., & P., B. (in press). Sexual behaviour in a cohort of 129 cases of Parkinson's disease in a Tertiary Care Hospital in Kolkata, India. Annals of Indian Academy of Neurology."},{"key":"10.1016\/bs.irn.2017.05.019_bb0055","series-title":"Eminent neuroscientists: Their lives and works","author":"Bhattacharyya","year":"2011"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.019_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0301-0082(92)90018-A","article-title":"Dopamine functions in appetitive and defensive behaviours","volume":"39","author":"Blackburn","year":"1992","journal-title":"Progress in Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00926230490258893","article-title":"Sexual dysfunction in Parkinson's disease","volume":"30","author":"Bronner","year":"2004","journal-title":"Journal of Sex & Marital Therapy"},{"key":"10.1016\/bs.irn.2017.05.019_bb0070","series-title":"Sexuality and Parkinson's disease","year":"2003"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1756285611411504","article-title":"Management of sexual dysfunction in Parkinson's disease","volume":"4","author":"Bronner","year":"2011","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp.53.6.480","article-title":"Sexual function in patients with Parkinson's disease and their partners","volume":"53","author":"Brown","year":"1990","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/jnnp.69.4.566a","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"69","author":"Cantello","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.019_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mdc3.12155","article-title":"Hypersexuality in Parkinson's disease: Systematic review and report of 7 new cases","volume":"2","author":"Codling","year":"2015","journal-title":"Movement Disorders Clinical Practice"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease","volume":"30","author":"Cools","year":"2006","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00002826-199704000-00005","article-title":"Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease","volume":"20","author":"Courty","year":"1997","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1743-6109.2007.00630.x","article-title":"Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors","volume":"5","author":"Csoka","year":"2008","journal-title":"The Journal of Sexual Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.019_bb0115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.parkreldis.2012.05.012","article-title":"Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease","volume":"18","author":"Cunnington","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.019_bb0120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mds.25105","article-title":"Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions?","volume":"27","author":"Djamshidian","year":"2012","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.019_bb0125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.019_bb0135","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinson's disease","volume":"17","author":"Evans","year":"2004","journal-title":"Current Opinion in Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s002130050880","article-title":"Facilitation of sexual behavior in male rats following D-amphetamine-induced behavioral sensitization","volume":"142","author":"Fiorino","year":"1999","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1743-6109.2005.00118.x","article-title":"Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study","volume":"2","author":"Fisher","year":"2005","journal-title":"The Journal of Sexual Medicine"},{"issue":"5854","key":"10.1016\/bs.irn.2017.05.019_bb0155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.1146157","article-title":"Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism","volume":"318","author":"Frank","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0160","first-page":"79","article-title":"Sexual disabilities, problems and satisfaction in 18\u201374 year old swedes","volume":"2","author":"Fugl-Meyer","year":"1999","journal-title":"Scandinavian Journal of Sexology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0165","doi-asserted-by":"crossref","first-page":"548","DOI":"10.12968\/bjnn.2010.6.1.46055","article-title":"Treating Parkinson's disease. Dopamine dysregulation syndrome and impulse control","volume":"6","author":"Gallagher","year":"2010","journal-title":"British Journal of Neuroscience Nursing"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.019_bb0170","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/aje\/kwm246","article-title":"Erectile function and risk of Parkinson's disease","volume":"166","author":"Gao","year":"2007","journal-title":"American Journal of Epidemiology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.019_bb0175","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrurol.2012.151","article-title":"Sex for fun: A synthesis of human and animal neurobiology","volume":"9","author":"Georgiadis","year":"2012","journal-title":"Nature Reviews. Urology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s007020050005","article-title":"Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease","volume":"107","author":"Giladi","year":"2000","journal-title":"Journal of Neural Transmission (Vienna, Austria: 1996)"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/01.wnl.0000194260.43583.32","article-title":"Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury","volume":"66","author":"Giuliano","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.019_bb0200","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.153.6.833","article-title":"Serial cognitive profiles in levodopa-induced hypersexuality","volume":"153","author":"Harvey","year":"1988","journal-title":"The British Journal of Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.019_bb0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0210","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp.69.4.550","article-title":"Sexuality in young patients with Parkinson's disease: A population based comparison with healthy controls","volume":"69","author":"Jacobs","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0220","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002826-199010000-00008","article-title":"Sexual dysfunction in Parkinson's disease","volume":"13","author":"Koller","year":"1990","journal-title":"Clinical Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.05.019_bb0225","article-title":"Should hypersexual disorder be classified as an addiction?","volume":"20","author":"Kor","year":"2013","journal-title":"Sexual Addiction & Compulsivity"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0230","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1743-6109.2008.01083.x","article-title":"Loss of libido in Parkinson's disease","volume":"6","author":"Kummer","year":"2009","journal-title":"The Journal of Sexual Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10508-006-8993-y","article-title":"High rates of sexual behavior in the general population: Correlates and predictors","volume":"35","author":"Langstrom","year":"2006","journal-title":"Archives of Sexual Behavior"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: Prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.019_bb0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","article-title":"Compulsive use of dopamine replacement therapy in Parkinson's disease: Reward systems gone awry?","volume":"2","author":"Lawrence","year":"2003","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between pathological gambling and substance use disorders: A focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.019_bb0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJMoa067423","article-title":"A study of sexuality and health among older adults in the United States","volume":"357","author":"Lindau","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.019_bb0265","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1212\/WNL.40.9.1347","article-title":"Sexual function in married men with Parkinson's disease compared to married men with arthritis","volume":"40","author":"Lipe","year":"1990","journal-title":"Neurology"},{"issue":"3-a","key":"10.1016\/bs.irn.2017.05.019_bb0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0004-282X2001000400014","article-title":"Assessment of erectile dysfunction in patients with Parkinson's disease","volume":"59","author":"Lucon","year":"2001","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jsxm.2015.12.019","article-title":"Definitions of sexual dysfunctions in women and men: A consensus statement from the fourth international consultation on sexual medicine 2015","volume":"13","author":"McCabe","year":"2016","journal-title":"The Journal of Sexual Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0285","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5694\/j.1326-5377.2003.tb05535.x","article-title":"Chronic illness and sexuality","volume":"179","author":"McInnes","year":"2003","journal-title":"The Medical Journal of Australia"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.019_bb0290","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.parkreldis.2007.04.004","article-title":"Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"13","author":"McKeon","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.parkreldis.2007.09.007","article-title":"Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease","volume":"14","author":"Merims","year":"2008","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0300","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0704773","article-title":"Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist","volume":"136","author":"Mizusawa","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"Suppl. 3","key":"10.1016\/bs.irn.2017.05.019_bb0305","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction","volume":"62","author":"Montejo","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1743-6109.2004.04025.x","article-title":"Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: A randomized, double-blind, placebo-controlled trial","volume":"1","author":"Montorsi","year":"2004","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/bs.irn.2017.05.019_bb0315","unstructured":"Non-motor symptoms of Parkinson's disease (Vol. II). (2009). New York: Oxford University Press."},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0320","first-page":"347","article-title":"Chronic illness and sexual functioning","volume":"67","author":"Nusbaum","year":"2003","journal-title":"American Family Physician"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management","volume":"23","author":"O'Sullivan","year":"2009","journal-title":"CNS Drugs"},{"issue":"Pt. 4","key":"10.1016\/bs.irn.2017.05.019_bb0330","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive\u2013compulsive behaviours","volume":"134","author":"O'Sullivan","year":"2011","journal-title":"Brain"},{"issue":"16","key":"10.1016\/bs.irn.2017.05.019_bb0335","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/mds.22848","article-title":"Pramipexole and gender identity disorder: Expanding the phenotype of hypersexuality in Parkinson's disease","volume":"24","author":"Odiyoor","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.019_bb0340","series-title":"An essay on the shaking palsy","author":"Parkinson","year":"1817"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2045125312470130","article-title":"Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: A review","volume":"3","author":"Poletti","year":"2013","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.019_bb0355","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11910-013-0386-8","article-title":"The functional anatomy of impulse control disorders","volume":"13","author":"Probst","year":"2013","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/bs.irn.2017.05.019_bb0360","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1192\/bjp.142.3.296","article-title":"Dopa dose-dependent sexual deviation","volume":"142","author":"Quinn","year":"1983","journal-title":"The British Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0370","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0302-2838(02)00054-4","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease","volume":"41","author":"Raffaele","year":"2002","journal-title":"European Urology"},{"issue":"9560","key":"10.1016\/bs.irn.2017.05.019_bb0375","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(07)60238-4","article-title":"Sexual function in men and women with neurological disorders","volume":"369","author":"Rees","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0380","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00002826-200207000-00008","article-title":"Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline","volume":"25","author":"Riley","year":"2002","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0385","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0893-133X(98)00091-8","article-title":"Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms","volume":"20","author":"Rogers","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.05.019_bb0390","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Autonomic Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0395","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.26099","article-title":"Management of impulse control disorders in Parkinson's disease: Controversies and future approaches","volume":"30","author":"Samuel","year":"2015","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0400","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A","article-title":"How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population","volume":"15","author":"Schrag","year":"2000","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0405","first-page":"62","article-title":"Chronic dopamimetic drug addiction and pathological gambling in patients with Parkinson's disease\u2014Presentation of four cases","volume":"2","author":"Serrano-Due\u00f1as","year":"2002","journal-title":"German Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.019_bb0410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JCP.0b013e31802e98c3","article-title":"Quetiapine in a case with Parkinson disease and pathological gambling","volume":"27","author":"Sevincok","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0415","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.parkreldis.2006.01.010","article-title":"Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: Report of 2 cases","volume":"12","author":"Shapiro","year":"2006","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.019_bb0420","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s10072-016-2668-9","article-title":"Hypersexuality induced by rasagiline in monotherapy in Parkinson's disease","volume":"37","author":"Simonet","year":"2016","journal-title":"Neurological Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0425","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.2006.102061","article-title":"Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease","volume":"78","author":"Smeding","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2010.02.006","article-title":"Long term follow-up of Parkinson's disease patients with impulse control disorders","volume":"16","author":"Sohtaoglu","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0435","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mds.26157","article-title":"Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature","volume":"30","author":"Solla","year":"2015","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0440","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pnpbp.2011.02.002","article-title":"Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications","volume":"35","author":"Solla","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0445","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archneur.63.2.299-b","article-title":"Association between pathologic gambling and parkinsonian therapy as detected in the food and drug administration adverse event database","volume":"63","author":"Szarfman","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2017.05.019_bb0450","article-title":"Parkinson's: A syndrome rather than a disease?","author":"Titova","year":"2016","journal-title":"Journal of Neural Transmission (Vienna, Austria: 1996)"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0455","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-198910000-00002","article-title":"Hypersexuality with antiparkinsonian therapy","volume":"12","author":"Uitti","year":"1989","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0460","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.parkreldis.2012.11.008","article-title":"Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases","volume":"19","author":"Vitale","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0465","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.23567","article-title":"Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease","volume":"26","author":"Vitale","year":"2011","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1017459","article-title":"Hypersexuality\u2014A complication of dopaminergic therapy in Parkinson's disease","volume":"16","author":"Vogel","year":"1983","journal-title":"Pharmacopsychiatria"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.019_bb0475","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson's disease: Recent advances","volume":"24","author":"Voon","year":"2011","journal-title":"Current Opinion in Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0480","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: A multicenter case\u2014Control study","volume":"69","author":"Voon","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2017.05.019_bb0485","series-title":"Parkinson's disease and nonmotor dysfunction","first-page":"173","article-title":"Impaired sexual function","author":"Waters","year":"2013"},{"issue":"Suppl. 2","key":"10.1016\/bs.irn.2017.05.019_bb0490","first-page":"S93","article-title":"Dopamine and impulse control disorders in Parkinson's disease","volume":"64","author":"Weintraub","year":"2008","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.019_bb0495","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0500","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000341996","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"11","author":"Weintraub","year":"2013","journal-title":"Neurodegenerative Diseases"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.019_bb0505","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/mds.870120614","article-title":"Sexuality in women with Parkinson's disease","volume":"12","author":"Welsh","year":"1997","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1041166","article-title":"Sexual aspects of Parkinson's disease","volume":"12","author":"Wermuth","year":"1992","journal-title":"Seminars in Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0515","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00019442-200403000-00013","article-title":"Dimensions of sexual dysfunction in Parkinson disease","volume":"12","author":"Yu","year":"2004","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.019_bb0520","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W","article-title":"Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease","volume":"15","author":"Zesiewicz","year":"2000","journal-title":"Movement Disorders"}],"container-title":["International Review of Neurobiology","Nonmotor Parkinson\u2019s: The Hidden Face - Management and the Hidden Face of Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T01:06:17Z","timestamp":1719277577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774217300636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128126035"],"references-count":104,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2017.05.019","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}